22/04/2019 16:09:17

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, April 22, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ: AKRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between August 1, 2018 and January 8, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before April 22, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Akorn downplayed the severity of violations at its Decatur, Illinois, manufacturing facility, misleading investors. The Company’s response to the FDA’s Form 483, which detailed the agency’s inspection of the facility, was found to be inadequate by the regulator. In fact, the Company repeatedly failed to correct manufacturing problems at this plant. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Akorn, investors suffered damages.

Join the case

to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

Sherin Mahdavian, Esq.,

www.schallfirm.com

Office: 310-301-3335

Cell: 424-303-1964

info@schallfirm.com

SOURCE:

The Schall Law Firm

Schall Firm Logo 2.jpg

Related content
25 Jun - 
Akorn Receives FDA Warning Letter
30 May - 
Akorn to Present at the Jefferies 2019 Global Healthcar..
20 May - 
Akorn Receives FDA Approval for Azelastine Hydrochlorid..
Related debate
08 May - 
nu har jeg brugt lidt tid på selskabet, de melder..
08 May - 
har desværre ikke så mange, men omsæt..
08 May - 
hold da, godt nok var ders regnskab i går rigtig ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Annual Financial Report and Notice of Annual General Meeting
2
Announcement about major shareholder
3
Start of Day Message
4
Hexatronic expands with new production facility to meet increased demand in the United States
5
Listing of Adapteo Plc on Nasdaq Stockholm (111/19)

Related stock quotes

Akorn Inc 4.670 -1.3% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 June 2019 04:12:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB7 - 2019-06-26 05:12:18 - 2019-06-26 04:12:18 - 1000 - Website: OKAY